InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Yablonka Uri. Officer active across 1 company, notably Brainstorm Cell Therapeutics INC.. Aggregated, 3 filings have been recorded. History available since 11 March 2024. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations